Pre-treatment of Flowers Extract of Abelmoschus manihot Medicus on Ischemia/Reperfusion Renal Injury in Rats
DOI:
https://doi.org/10.46966/msjar.v6i3.309Keywords:
Abelmoschus manihot (Linnaeus) Medicus (Malvaceae) (AM), Ischemia/Reperfusion (I/R), Oxidative stressAbstract
Background and Aim: The purpose of this study is to provide a basic data with the use of flowers extract of Abelmoschus manihot (Linnaeus) Medicus (Malvaceae) (AM) as a herbal agent against renal oxidative stress. Materials and Methods: Pre-treatment effect of flowers extract of AM in rat with renal ischemia/reperfusion(I/R) injury was investigated. Renal I/R injury in rat were induced by clamping of the left and right renal arteries for 45 min followed by 24 h of reperfusion after administration of flowers extract of AM for 30 days. The effect of flowers extract of AM was evaluated through the measurement of renal function and the relevant parameters of oxidative stress. Results: Renal I/R injury led to renal dysfunction as evidenced by higher serum BUN and creatinine along with increase in oxidative stress in renal tissues compared with Sham group. Pre- treatment of flowers extract of AM decreased serum BUN, creatinine, and renal MDA levels, and increased SOD, CAT and GSH-PX activities in the kidney. Conclusion: Collectively, these data indicated that flowers extract of AM could be used as a safe and natural antioxidant for the protection of oxidative stress in kidney.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jinsong O, Cholyong O, Sinhyok Paek, Yongsu Ri, Yongjae Kang, Yongjun Kim, Songchan Han, Hyon-Song Jang

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















